How broadly expressed transcription factors contribute to tissue-specific gene expression is not well understood. Andzelm, Cherry et al. (2015) demonstrate that myocyte enhancer factor 2D (MEF2D) binds and activates retina-specific regulatory regions by cooperative interaction with the tissue-specific transcription factor CRX.
As multicellular organisms evolved, so did the mechanisms for the regulation of cell-and tissue-specific gene expression. The need for exquisitely precise cell type-specific gene regulation is particularly evident in the nervous system with its enormous degree of cell type diversity, a degree of diversity whose complexity is being further appreciated through the recent application of singlecell transcriptomic technologies to the study of individual neurons (Zeisel et al., 2015) . Early models of transcriptional regulation, which centered on the combinatorial activity of a relatively limited number of partially differentially expressed transcription factors (TFs) to achieve cell type specificity, have evolved into more complex models that integrate differential binding to enhancer elements, epigenetic and other variations in chromatin structure that affect accessibility to regulatory molecules, and protein-protein interactions between regulatory factors that are modified by post-transcriptional processing. A particularly interesting and relatively unexplored aspect of tissue-specific gene regulation is how widely expressed transcription factors can act to modulate the expression of cell type-specific genes. In this issue, Andzelm, Cherry et al. (2015) provide insight into this question by showing that myocyte enhancer factor 2D (MEF2D), a widely expressed protein, can be commandeered to contribute to cell type-specific differentiation and function through interaction with a more specifically expressed regulatory molecule, i.e., they show that a transcription factor's specificity can be influenced by who it ''hangs out with.'' As a model system to study transcription factor specificity, Andzelm, Cherry et al. chose to focus on the MEF2 family of regulatory molecules. The MEF2 proteins play important roles in development, cell survival, and response to stimulus. Although widely expressed, they have very specific effects on muscle, the central nervous system (CNS), bone, and bone marrow-derived cells. In the CNS, they influence neuronal differentiation, cell survival, and synapse formation. All MEF2 proteins contain highly conserved MADS and MEF2 domains that are important for DNA binding and interaction with other factors. Mutations in the MEF2s are associated with neurological disorders such as epilepsy, mental retardation, and autism (Elmer et al., 2013) .
After considering several possibilities, the authors settled upon the retina for their analysis because, unlike other regions of the CNS that generally co-express multiple MEF2 proteins, which could complicate interpretation of their results, they found that developing retinal photoreceptors predominantly express MEF2D. Murine photoreceptors are approximately 97% rods and 3% cones, with the cones consisting of two classes, short-wavelength (S) and middle-wavelength (M) cones. Both rods and cones are ciliated cells that have morphologically unique and highly polarized structures. The outer segments (OS), as the name implies, are the outermost parts of the cell; they contain stacks of membrane (''discs'') that are densely packed with photopigments (rhodopsin in rods and cone opsin in cones) and associated proteins that carry out phototransduction, and they abut the retinal pigment epithelium (RPE), which is important for the visual cycle and for outer segment maintenance and phagocytosis.
The work of Andzelm, Cherry et al., as well as a recent study by Omori et al. (Omori et al., 2015) , demonstrates that MEF2D is necessary for normal retinal development. Both groups engineered novel Mef2d KO mice in which exons 2-6, or exons 2-4, respectively, which encode the entire MADS and MEF2 domains, were deleted. Although at postnatal day 11 (P11) the retinas of the Mef2d KO mice appeared normal, at older ages they displayed clear photoreceptor abnormalities, exhibiting shortened outer segments, progressive loss of photoreceptors, altered expression of multiple photoreceptor-and bipolar cellexpressed genes, abnormal synapse formation, and impaired electrophysiological responses as measured by electroretinogram (ERG). At the molecular level, Omori et al. found that MEF2D synergistically transactivates cone arrestin promoter activity in HEK293T cells in cooperation with cone-rod homeobox (CRX), a cell type-specific transcription factor that is essential for normal photoreceptor development and that is expressed predominantly in rods and cones, but also, at a lower level, in bipolar and RPE cells (Esumi et al., 2009; Hennig et al., 2008) .
Andzelm, Cherry et al. then went on to derive key new insights into the mechanisms by which MEF2D regulates photoreceptor-specific gene expression through the elegant application of extensive and carefully controlled genomic studies of their Mef2d KO mice. RNAseq was used to compare P11 wild-type (WT) and Mef2d KO P11 retinas. P11 was chosen for the analysis because at this developmental time point, as compared to later time points, differences in retinal gene expression are more likely to reflect Mef2d disruption itself rather than secondary downstream degenerative effects, as the Mef2d KO retinas at this stage are morphologically indistinguishable from WT retinas. The analysis identified 185 genes that were significantly misregulated in the Mef2d KO retina, and this set of misregulated genes was highly enriched for retina-specific and retina-enriched genes.
MEF2D ChIP-seq analysis of WT retinas, also performed at P11, revealed that MEF2D demonstrates a unique pattern of binding in the retina, with extensive binding observed to the enhancer and promoter regions of retina-specific genes. Before discussing in more detail the binding data itself, it is worth noting a significant technical aspect of the work that highlights the potential noise in ChIP-seq experiments, the importance of controls, and the need for caution in interpretation. The ChIP-seq data with WT retinas was performed with two biological replicates. The replicates were consistent in the sense that each identified approximately 12,000 MEF2D binding sites; however, only about 4,000 sites overlapped between the two replicates. Of potentially even greater concern, many of the identified binding sites, even many of those that overlapped between the replicates, were still observed in negative control experiments performed with the Mef2d KO retinas. After correcting for all these false positives, a set of 2,403 ''high confidence'' binding sites was defined.
Analysis of the filtered set of 2,403 binding sites revealed a pattern of MEF2D binding in the retina that was very different from that seen with cortical neurons and C2C12 myocytes. The great majority of the sites (2,003/2,403 hits) were greater than 1,000 base pairs from the nearest known transcription start site, and these sites were defined as enhancer sites, although it should be noted that for the majority of these it is not clear that they actually represent functional enhancers. As might be expected, MEF2D binding sites were found to be enriched near the 185 genes that are misregulated in the Mef2d KO mice. Most significantly, the authors found that approximately 70% of the MEF2D binding sites that are associated with retina-specific genes are co-bound by CRX. Based on this observed coincidence of binding sites, suggesting that MEF2D-mediated retina-specific gene regulation might be achieved through co-regulation with CRX, the authors asked whether CRX is required for the binding of MEF2D to retina-specific enhancers/promoters. By comparing MEF2D ChIP-seq results from Crx KO mouse retinas with those from WT retinas, they defined regions where MEF2D binding was reduced, unchanged, or increased by the loss of CRX expression. Regions of CRX-dependent MEF2D binding loss were predominantly observed in the enhancers/promoters of retina-specific genes. Intriguingly, their analysis also revealed that the canonical MEF2-responsive element (MRE) was de-enriched from the region where MEF2D binding depended on CRX, while the canonical MRE was enriched in the region where MEF2D binding increased in the absence of CRX (the MRE enriched regions are the regulatory regions of non-retinal genes). These results suggest that CRX recruits MEF2D, redistributing it to retina-specific gene regulatory regions, even though many lack a canonical MRE, from the canonical MREs of non-retinal gene regulatory regions, and stabilizes its binding to these sites. Additionally, the authors provide data indicating that the MEF2D-CRX interaction regions are generally functionally active as defined by acetylation of H3K27 and expression of enhancer RNAs (eRNAs).
The work of Andzelm, Cherry et al. also has potential clinical significance in that their Mef2d KO mice, as well as those generated by Omori et al., demonstrate a retinal degeneration phenotype. This finding, together with MEF2D's close functional connection with CRX, which itself when mutated can cause a variety of retinal degenerations, strongly suggests that functional defects of MEF2D could potentially be associated with retinal disease. The authors' identification of >2,000 retina-specific MEF2D binding enhancers as well their comprehensive mapping of active promoters/enhancers (identified by H3K27Ac ChIP-seq and eRNA expression) provides useful new substrates to help address the question of if and how genetic variation within these enhancer regions could influence PR development, susceptibility to disease-causing stresses such as oxidative and endoplasmic reticulum stress, and the development of neurodegenerative diseases such as retinitis pigmentosa and age-related macular degeneration. Comprehensive sequence analysis of these enhancer sequences in patient and control populations could lead to the identification of novel genetic risk factors for the development of human retinal disease.
As with many new findings, the elucidation by Andzelm, Cherry et al. that widely expressed transcription factors can be commandeered by tissue-specific factors to expand the repertoire of regulatory sites dictating tissue-specific gene expression opens doors to multiple interesting new questions. An intriguing issue that arises from this work is how the cooperative function of MEF2D and CRX is established and maintained. A physical interaction between the two proteins has not been reported, but should be explored since such an interaction would provide an obvious mechanism by which CRX could redistribute MEF2D protein away from strong MEF2D DNA binding sites to non-canonical sites. Whether altered MEF2D binding is due to some MEF2D modification that may alter its DNA binding affinity and/or its DNA recognition or whether MEF2D is incorporated into a different chromatin binding complex in the presence of CRX is also not yet clear. A related question is how expression levels of the associated tissue-specific and general TFs alter the balance of the affinity of the TF to its traditional binding site relative to the tissue-specific binding sites. One can imagine that recruitment of MEF2D (and potentially other non-specific factors, if this is a general mechanism) to tissue-specific rather than canonical binding sites could be regulated by altering the cellular concentration of the tissue-specific factor(s) that redistributes the more generally expressed factor, especially if the level of MEF2D protein within photoreceptors is limiting. This could be part of an exquisitely controlled network of regulation though development, one that when disrupted could be associated with a disease state. Besides the potential importance of protein levels, splice variants, post-translational modifications, compartmentalization, DNA methylation state, and chromatin status can all conceivably contribute to dynamic changes in the equilibrium of a general TF binding to either classical or tissuespecific sites. Since, as the authors also suggest, CRX regulates MEF2D activity in an additional, DNA-binding independent mode, dissecting what specific elements and/or additional factors contribute to the functional interactions of CRX with MEF2D could help to elucidate this whole new dimension of tissue-specific gene regulation. Neuron, Bruno et al. (2015) use large-scale recordings in Aplysia, and apply novel dimensionality-reduction techniques to define dynamical building blocks involved in locomotor behavior. These techniques open new avenues to the study of neuronal networks.
In this issue of
One key goal of neuroscientists is to understand how neural circuits produce behavior. While circuit function has been studied in a multitude of species, including humans, it is arguably studies of invertebrates that have yielded the greatest insights into underlying circuit mechanisms.
Through studies of the mollusc, Tritonia, in the 1970s and 1980s, Peter Getting established a sequential 8-step approach to circuits producing rhythmic movements (Getting, 1986) : (a) describe the behavior; (b) characterize the motor pattern; (c) identify the neurons involved; (d) localize the key neurons involved; (e) map the synaptic connectivity; (f) characterize the cellular properties; (g) manipulate the network; and (h) reconstruct the network. In the ensuing 30 years, great strides have been made in invertebrates and vertebrates alike in at least the first three steps and to varying degrees in the others (Brownstone and Wilson, 2008).
Although this step-wise approach is quite logical, there are several meta-problems with it. For one, individual neurons may be involved in more than one motor behavior, meaning that there are not specific circuits dedicated to each motor program (Getting, 1989; Wu et al., 1994) . In addition, in all but the simplest nervous systems, many dozens to hundreds to thousands of neurons may be involved in producing the activity, presenting a key stumbling block in the capacity to simultaneously record large numbers of neurons. And if this could be accomplished, how is the large volume of data then to be analyzed? In other words, a major stumbling block in understanding the CNS is its high dimensionality. In order to understand these networks, it is necessary to parse these large datasets using methods aimed at reducing their dimensionality (Cunningham and Yu, 2014; O'Leary and Marder, 2014; Vogelstein et al., 2014) . So while the linear approach proposed by Getting (1989) is particularly well-suited for conventional analysis, it implies a reductionism that does not necessarily pair with the multidimensionality of the CNS.
In this issue of Neuron, Bruno et al. (2015) use new techniques in a traditional preparation to ask how large numbers of neurons assemble to produce a behavior. They studied the escape motor program in Aplysia. By mimicking a noxious stimulus applied to the tail, they induced rolling waves of dorsal and ventral activity along the antero-posterior axis of the animal. This locomotor behavior is produced by the pedal ganglion, which contains 1,600 neurons, including pattern generators, modulator neurons, and motoneurons. Bruno et al. (2015) used an approach in which they combined large-scale recordings with high temporal and spatial resolution to simultaneously record dozens of neurons. They then reduced the
